Comparative quantitative structure-activity relationship studies on anti-HIV drugs

被引：268

作者：

Garg, R

Gupta, SP ^{[1
]}

Gao, H

Babu, MS

Debnath, AK

Hansch, C

机构：

[1] Pomona Coll, Dept Chem, Claremont, CA 91711 USA

[2] Birla Inst Technol & Sci, Dept Chem, Pilani 333031, Rajasthan, India

[3] Birla Inst Technol & Sci, Dept Pharm, Pilani 333031, Rajasthan, India

[4] Pharmacia & Upjohn Inc, Kalamazoo, MI 49007 USA

[5] Lindsley F Kimball Res Inst, New York Blood Ctr, Biochem Virol Lab, New York, NY 10021 USA

来源：

CHEMICAL REVIEWS | 1999年 / 99卷 / 12期

关键词：

D O I：

10.1021/cr9703358

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：3525 / 3601

页数：77

共 197 条

[21] HIV PROTEINASE-INHIBITORS CONTAINING 2-AMINOBENZYLSTATINE AS A NOVEL SCISSILE BOND REPLACEMENT - BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION [J].

BILLICH, A ;

CHARPIOT, B ;

FRICKER, G ;

GSTACH, H ;

LEHR, P ;

PEICHL, P ;

SCHOLZ, D ;

ROSENWIRTH, B .

ANTIVIRAL RESEARCH, 1994, 25 (3-4) :215-233

[22]

Boehme RE, 1995, ANNU REP MED CHEM, V30, P139

[23] IMMUNOPATHOGENESIS OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].

BOWEN, DL ;

LANE, HC ;

FAUCI, AS .

ANNALS OF INTERNAL MEDICINE, 1985, 103 (05) :704-709

[24]

BRESLIN HJ, 1995, J MED CHEM, V38, P771, DOI 10.1021/jm00005a005

[25] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF PHENYLENEBIS(METHYLENE)-LINKED BIS-TETRAAZAMACROCYCLES THAT INHIBIT HIV REPLICATION - EFFECTS OF MACROCYCLIC RING SIZE AND SUBSTITUENTS ON THE AROMATIC LINKER [J].

BRIDGER, GJ ;

SKERLJ, RT ;

THORNTON, D ;

PADMANABHAN, S ;

MARTELLUCCI, SA ;

HENSON, GW ;

ABRAMS, MJ ;

YAMAMOTO, N ;

DEVREESE, K ;

PAUWELS, R ;

DECLERCQ, E .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (02) :366-378

[26]

BRODER S, 1985, LANCET, V2, P627

[27] 3'-SPIRO NUCLEOSIDES, A NEW CLASS OF SPECIFIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INHIBITORS - SYNTHESIS AND ANTIVIRAL ACTIVITY OF [2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-BETA-D-XYLO AND RIBOFURANOSE]-3'-SPIRO-5''-[4''-AMINO-1'',2''-OXATHIOLE 2'',2''-DIOXIDE] (TSAO) PYRIMIDINE NUCLEOSIDES [J].

CAMARASA, MJ ;

PEREZPEREZ, MJ ;

SANFELIX, A ;

BALZARINI, J ;

DECLERCQ, E .

JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (15) :2721-2727

[28] Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P-1/P-1' compounds: Correlation between lipophilicity and cytotoxicity [J].

Chen, P ;

Cheng, PTW ;

Alam, M ;

Beyer, BD ;

Bisacchi, GS ;

Dejneka, T ;

Evans, AJ ;

Greytok, JA ;

Hermsmeier, MA ;

Humphreys, WG ;

Jacobs, GA ;

Kocy, O ;

Lin, PF ;

Lis, KA ;

Marella, MA ;

Ryono, DE ;

Sheaffer, AK ;

Spergel, SH ;

Sun, CQ ;

Tino, JA ;

Vite, G ;

Colonno, RJ ;

Zahler, R ;

Barrish, JC .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (10) :1991-2007

[29] RELATIVE BINDING FREE-ENERGIES OF PEPTIDE INHIBITORS OF HIV-1 PROTEASE - THE INFLUENCE OF THE ACTIVE-SITE PROTONATION STATE [J].

CHEN, XN ;

TROPSHA, A .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (01) :42-48

[30] STRUCTURE ACTIVITY RELATIONSHIPS OF PYRIMIDINE NUCLEOSIDES AS ANTIVIRAL AGENTS FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].

CHU, CK ;

SCHINAZI, RF ;

AHN, MK ;

ULLAS, GV ;

GU, ZP .

JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) :612-617

← 1 2 3 4 5 6 7 8 9 10 →